PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+17.53%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$183M
AUM Growth
+$183M
(+4.6%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
12.01%
Top 10 Holdings %
Top 10 Hldgs %
98.91%
Holding
12
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Neuronetics
STIM
|
$21.9M |
| 2 |
Pulmatrix
PULM
|
$359K |
Top Sells
| 1 |
TTOO
T2 Biosystems, Inc
TTOO
|
$260K |
Sector Composition
| 1 | Healthcare | 60.97% |
| 2 | Communication Services | 31.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cardlytics
CDLX
$54.3M
| $57.4M | 31.26% |
2,636,262
| – | – |
|
2
Fate Therapeutics
FATE
$120M
| $28M | 15.28% |
2,473,186
| – | – |
|
3
KALA BIO
KALA
$78.8M
| $25.5M | 13.9% |
1,857,582
| – | – |
|
|
4
Neuronetics
STIM
$220M
| $21.9M | 11.96% |
+824,765
| New | +$21.9M |
|
5
Cartesian Therapeutics
RNAC
$261M
| $21.3M | 11.6% |
1,606,813
| – | – |
|
|
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
| $14.3M | 7.77% |
1,841,924
-33,600
| -2% | -$260K |
|
7
X4 Pharmaceuticals
XFOR
$84.2M
| $6.78M | 3.7% |
1,868,957
| – | – |
|
|
TRVN
8
DELISTED
Trevena, Inc.
TRVN
| $2.96M | 1.61% |
2,053,540
| – | – |
|
|
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.69M | 0.92% |
1,968,606
| – | – |
|
|
ATYR
10
aTyr Pharma
ATYR
$527M
| $1.66M | 0.91% |
1,827,992
| – | – |
|
|
11
Pulmatrix
PULM
$18M
| $1.62M | 0.88% |
3,594,381
+797,974
| +29% | +$359K |
|
12
Dare Bioscience
DARE
$27.2M
| $382K | 0.21% |
326,243
| – | – |
|